NL
DE
Less damage to organs and a greater chance of survival after having a heart attack. That's what Radboudumc spin-off CardiacBooster is aiming to accomplish.
Related news items
ATRO Medical starts unique meniscus study
1 November 2024As the first worldwide, ATRO Medical is starting a clinical study on the function of an artificial outer meniscus, the lateral meniscus. This is a first: never before has a removed lateral meniscus been replaced by a plastic specimen, the Artimis® Meniscus Prosthesis.
read more
Third Radboudumc Investment Day again well-attended
16 October 2023On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.
read more
Soteria Medical BV announces collaboration with ALLEAD
27 July 2023Radboudumc spin-off Soteria Medical BV announces collaboration with ALLEAD.
read more
Boosting the startup ecosystem in Nijmegen!
22 June 2023TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.
read more